Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-pass sequencing for microbial comparative genomics.
Goo YA, Roach J, Glusman G, Baliga NS, Deutsch K, Pan M, Kennedy S, DasSarma S, Ng WV, Hood L. Goo YA, et al. Among authors: kennedy s. BMC Genomics. 2004 Jan 12;5(1):3. doi: 10.1186/1471-2164-5-3. BMC Genomics. 2004. PMID: 14718067 Free PMC article.
Genomic and genetic dissection of an archaeal regulon.
Baliga NS, Kennedy SP, Ng WV, Hood L, DasSarma S. Baliga NS, et al. Among authors: kennedy sp. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2521-5. doi: 10.1073/pnas.051632498. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226271 Free PMC article.
Genome sequence of Halobacterium species NRC-1.
Ng WV, Kennedy SP, Mahairas GG, Berquist B, Pan M, Shukla HD, Lasky SR, Baliga NS, Thorsson V, Sbrogna J, Swartzell S, Weir D, Hall J, Dahl TA, Welti R, Goo YA, Leithauser B, Keller K, Cruz R, Danson MJ, Hough DW, Maddocks DG, Jablonski PE, Krebs MP, Angevine CM, Dale H, Isenbarger TA, Peck RF, Pohlschroder M, Spudich JL, Jung KW, Alam M, Freitas T, Hou S, Daniels CJ, Dennis PP, Omer AD, Ebhardt H, Lowe TM, Liang P, Riley M, Hood L, DasSarma S. Ng WV, et al. Among authors: kennedy sp. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12176-81. doi: 10.1073/pnas.190337797. Proc Natl Acad Sci U S A. 2000. PMID: 11016950 Free PMC article.
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients.
Yazici Y, Tambiah JRS, Swearingen CJ, Lopez VA, Kennedy S, Fineman MS, Simsek I, Solomon E, Mcalindon TE. Yazici Y, et al. Among authors: kennedy s. Clin Exp Rheumatol. 2025 Jan 13. doi: 10.55563/clinexprheumatol/gskbin. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 39808288
Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study.
Yazici Y, Tambiah JRS, Swearingen CJ, Britt J, Kennedy S, Fineman MS, Simsek I, Solomon E, McAlindon TE. Yazici Y, et al. Among authors: kennedy s. Clin Exp Rheumatol. 2025 Jan 13. doi: 10.55563/clinexprheumatol/hjt118. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 39808286
3,160 results